Fareva acquires former Merck API manufacturing facility
Acquisition adds another world-class facility to the company's pool of 35 facilities in 11 countries
Fareva has taken possession of the former MSD site of La Vallée in Saint-Germain Laprade near Le Puy en Velay (Haute-Loire), France. This acquisition adds another facility to its pool of 35 in 11 countries.
La Vallée offers 30 years of experience in the manufacture of complex APIs and has 130 highly qualified employees. It has state-of-the-art installations in production, quality control and environmental systems.
With a total reactor capacity of 128,000L in large- and small-scale workshops, it nearly doubles Fareva’s API capacity from the existing facilities in Feucht (Excella/Germany), Val de Reuil (Valdepharm/France) and Romainville (Fareva Romainville/France).
Following its strategy of investment into niche technologies, Fareva is going to further strengthen the capabilities of the site by investing €2m into an OEB 4 high-containment facility. Two separated compartments with 4000L reactors and high-containment dryers will be operational mid-2017.
In addition, a hastelloy flow train for cryogenic chemistry at the 2–10m3 scale is also under development. Thanks to space available in the plant, additional production facilities can be added to satisfy potential customers.
Fareva La Vallée was built in 1985 and has an excellent track record in regulatory inspections by all major authorities. The site manufactures large and small volume APIs for highly regulated markets. Additionally, the safety culture on site is outstanding. There has never been an environmental incident in the 30-year history of the site, and no lost time accident for the last 2 years.
Fareva specialises in custom manufacturing for the pharmaceutical, cosmetics and household chemicals industries with more than 1000 customers worldwide and a global turnover of more than €1.3bn in 2014.
